Bond Celgen Corporation 5% ( US151020AU84 ) in USD
| Issuer | Celgen Corporation |
| Market price | |
| Country | United States
|
| ISIN code |
US151020AU84 ( in USD )
|
| Interest rate | 5% per year ( payment 2 times a year) |
| Maturity | 14/08/2045 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 2 000 000 000 USD |
| Cusip | 151020AU8 |
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) |
| Moody's rating | N/A |
| Next Coupon | 15/02/2026 ( In 61 days ) |
| Detailed description |
Celgene Corporation was a biopharmaceutical company acquired by Bristol Myers Squibb in 2019, known for its development and commercialization of cancer therapies and other immunology treatments. The Bond issued by Celgen Corporation ( United States ) , in USD, with the ISIN code US151020AU84, pays a coupon of 5% per year. The coupons are paid 2 times per year and the Bond maturity is 14/08/2045 The Bond issued by Celgen Corporation ( United States ) , in USD, with the ISIN code US151020AU84, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States